Literature DB >> 19860578

Consensus statement on the terminology and classification of central neck dissection for thyroid cancer.

Sally E Carty, David S Cooper, Gerard M Doherty, Quan-Yang Duh, Richard T Kloos, Susan J Mandel, Gregory W Randolph, Brendan C Stack, David L Steward, David J Terris, Geoffrey B Thompson, Ralph P Tufano, R Michael Tuttle, Robert Udelsman.   

Abstract

BACKGROUND: The primary goals of this interdisciplinary consensus statement are to review the relevant anatomy of the central neck compartment, to identify the nodal subgroups within the central compartment commonly involved in thyroid cancer, and to define a consistent terminology relevant to the central compartment neck dissection.
SUMMARY: The most commonly involved central lymph nodes in thyroid carcinoma are the prelaryngeal (Delphian), pretracheal, and the right and left paratracheal nodal basins. A central neck dissection includes comprehensive, compartment-oriented removal of the prelaryngeal and pretracheal nodes and at least one paratracheal lymph node basin. A designation should be made as to whether a unilateral or bilateral dissection is performed and on which side (left or right) in unilateral cases. Lymph node "plucking" or "berry picking" implies removal only of the clinically involved nodes rather than a complete nodal group within the compartment and is not recommended. A therapeutic central compartment neck dissection implies that nodal metastasis is apparent clinically (preoperatively or intraoperatively) or by imaging (clinically N1a). A prophylactic/elective central compartment dissection implies nodal metastasis is not detected clinically or by imaging (clinically N0).
CONCLUSION: Central neck dissection at a minimum should consist of removal of the prelaryngeal, pretracheal, and paratracheal lymph nodes. The description of a central neck dissection should include both the indication (therapeutic vs. prophylactic/elective) and the extent of the dissection (unilateral or bilateral).

Entities:  

Mesh:

Year:  2009        PMID: 19860578     DOI: 10.1089/thy.2009.0159

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  146 in total

Review 1.  Well differentiated thyroid carcinoma: current treatment.

Authors:  J Kenneth Byrd; Robert J Yawn; Christina S T Wilhoit; Nicoleta D Sora; Linda Meyers; Jyotika Fernandes; Terry Day
Journal:  Curr Treat Options Oncol       Date:  2012-03

2.  Pattern of initial metastasis in the cervical lymph node from papillary thyroid carcinoma.

Authors:  Naoyoshi Onoda; Tetsuro Ishikawa; Hidemi Kawajiri; Tsutomu Takashima; Kosei Hirakawa
Journal:  Surg Today       Date:  2012-06-26       Impact factor: 2.549

3.  Quantification of lymph nodes in the central compartment of the neck: a cadaveric study.

Authors:  Enyinnaya Ofo; Selvam Thavaraj; Daron Cope; James Barr; Karan Kapoor; Jean-Pierre Jeannon; Richard Oakley; Claire Lock; Edward Odell; Ricard Simo
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-11-20       Impact factor: 2.503

4.  Prediction of ipsilateral and contralateral central lymph node metastasis in unilateral papillary thyroid carcinoma: a retrospective study.

Authors:  Qiang Chen; Xiu-He Zou; Tao Wei; Qiu-Shi Huang; Ying-He Sun; Jing-Qiang Zhu
Journal:  Gland Surg       Date:  2015-08

5.  Evaluation of postoperative radioactive iodine scans in patients who underwent prophylactic central lymph node dissection.

Authors:  Amanda M Laird; Paul G Gauger; Barbra S Miller; Gerard M Doherty
Journal:  World J Surg       Date:  2012-06       Impact factor: 3.352

Review 6.  Controversies in the Management of Low-Risk Differentiated Thyroid Cancer.

Authors:  Megan R Haymart; Nazanene H Esfandiari; Michael T Stang; Julia Ann Sosa
Journal:  Endocr Rev       Date:  2017-08-01       Impact factor: 19.871

7.  Preoperative ultrasound evaluation of laterocervical lymph nodes: timing and experience modify the treatment of patients with differentiated thyroid cancer.

Authors:  Marica Grasso; Alessandro Puzziello; Maurizio De Palma
Journal:  Updates Surg       Date:  2019-01-02

Review 8.  German Association of Endocrine Surgeons practice guideline for the surgical management of malignant thyroid tumors.

Authors:  Henning Dralle; Thomas J Musholt; Jochen Schabram; Thomas Steinmüller; Andreja Frilling; Dietmar Simon; Peter E Goretzki; Bruno Niederle; Christian Scheuba; Thomas Clerici; Michael Hermann; Jochen Kußmann; Kerstin Lorenz; Christoph Nies; Peter Schabram; Arnold Trupka; Andreas Zielke; Wolfram Karges; Markus Luster; Kurt W Schmid; Dirk Vordermark; Hans-Joachim Schmoll; Reinhard Mühlenberg; Otmar Schober; Harald Rimmele; Andreas Machens
Journal:  Langenbecks Arch Surg       Date:  2013-03-03       Impact factor: 3.445

9.  Association of BRAF V600E Mutation and MicroRNA Expression with Central Lymph Node Metastases in Papillary Thyroid Cancer: A Prospective Study from Four Endocrine Surgery Centers.

Authors:  Patricia Aragon Han; Hyun-seok Kim; Soonweng Cho; Roghayeh Fazeli; Alireza Najafian; Hunain Khawaja; Melissa McAlexander; Benzon Dy; Meredith Sorensen; Anna Aronova; Thomas J Sebo; Thomas J Giordano; Thomas J Fahey; Geoffrey B Thompson; Paul G Gauger; Helina Somervell; Justin A Bishop; James R Eshleman; Eric B Schneider; Kenneth W Witwer; Christopher B Umbricht; Martha A Zeiger
Journal:  Thyroid       Date:  2016-03-07       Impact factor: 6.568

10.  Prognostic Value of the Number of Retrieved Lymph Nodes in Pathological Nx or N0 Classical Papillary Thyroid Carcinoma.

Authors:  Tae-Yon Sung; Jong Ho Yoon; Dong Eun Song; Yu-Mi Lee; Tae-Yong Kim; Ki-Wook Chung; Won Bae Kim; Young Kee Shong; Suck Joon Hong
Journal:  World J Surg       Date:  2016-08       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.